Blocking the TIM3 pathway stimulates tumor antigen-specific T cell proliferation and cytotoxic functions, inhibits the activity of Tregs [71], and decreases the presence of myeloid-derived suppressor cells (MDSCs) in tumors [72]. This evidence concerns the gene HAVCR2 and neoplasm.